Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis
News
KCL project receives £100,000 UK government funding to boost AI-assisted healthcare
The project will assist researchers and companies in training the technology for healthcare settings
Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Study reveals new liquid biopsy test could benefit thousands of lung cancer patients
The third most common and serious form of cancer affects over 43,000 people every year in the UK
Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Collaborators form national NHS patient database registry for Lynch syndrome patients
The genetic condition affects one in 279 people in England and significantly increases cancer risk
Researchers reveal people with Parkinson’s more likely to experience delirium in hospital
Two out of three people with the neurodegenerative condition experienced delirium in hospital
Strand Therapeutics develops new class of mRNA molecules for cancer
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
University of Liverpool to lead £125m research facility supported by UKRI investment
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research
PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets
Researchers identify group of biological markers found in high levels in TB patients
According to the World Health Organization, TB is responsible for over one million annual deaths
Inizio Engage and Applied Driving partner to support clinical workers with safety app
The Companion+ Mobile Safety App will be rolled out to a further 115 users within the UK and US
Francis Crick researchers target cancer cells’ ability to survive at low oxygen levels
LDHA and GOT1 enzymes successfully targeted and halted energy production in hard-to-reach cancer cells
